tiprankstipranks
Eli Lilly & Co (LLY)
NYSE:LLY
US Market
LLY
Eli Lilly & Co
RESEARCH TOOLSreports

Eli Lilly & Co (LLY) Stock Forecast & Price Target

21,378 Followers
See the Price Targets and Ratings of:

LLY Analyst Ratings

Strong Buy
21Ratings
Strong Buy
18 Buy
2 Hold
1 Sell
Based on 21 analysts giving stock ratings to
Eli
Lilly & Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LLY Stock 12 Month Forecast

Average Price Target

$1,249.83
▲(30.94% Upside)
Based on 21 Wall Street analysts offering 12 month price targets for Eli Lilly & Co in the last 3 months. The average price target is $1,249.83 with a high forecast of $1,500.00 and a low forecast of $850.00. The average price target represents a 30.94% change from the last price of $954.52.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"729":"$729","922":"$922","1115":"$1,115","1308":"$1,308","1501":"$1,501"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1500,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.50K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1249.83,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.25K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":850,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$850.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[729,922,1115,1308,1501],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,954.52,996.48,1038.44,1080.4,1122.36,1164.32,1206.28,1248.24,1290.2,1332.1599999999999,1374.12,1416.08,1458.04,{"y":1500,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,954.52,977.2361538461538,999.9523076923076,1022.6684615384615,1045.3846153846152,1068.1007692307692,1090.816923076923,1113.5330769230768,1136.2492307692307,1158.9653846153847,1181.6815384615384,1204.3976923076923,1227.113846153846,{"y":1249.83,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,954.52,946.48,938.4399999999999,930.4,922.36,914.3199999999999,906.28,898.24,890.2,882.16,874.12,866.0799999999999,858.04,{"y":850,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":799.311,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 63,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":788.263,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":743.149,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 75,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":771.776,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 76,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":758.278,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 82,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":730.286,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 80,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":822.836,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 93,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":860.159,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 90,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1056.127,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 90,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1072.889,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 71,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1042.39,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 71,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1017.97,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 91,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":954.52,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 82,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,500Average Price Target$1,250Lowest Price Target$850.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on LLY
Srikripa Devarakonda
Truist Financial
Truist Financial
―
Buy
―
Reiterated
04/02/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen Analyst forecast on LLY
Steve Scala
TD Cowen
TD Cowen
$1,250
Buy
30.96%
Upside
Reiterated
04/02/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Guggenheim Analyst forecast on LLY
Seamus Fernandez
Guggenheim
Guggenheim
$1,163
Buy
21.84%
Upside
Assigned
04/01/26
Eli Lilly price target lowered to $1,163 from $1,168 at GuggenheimEli Lilly price target lowered to $1,163 from $1,168 at Guggenheim
Wells Fargo Analyst forecast on LLY
Mohit Bansal
Wells Fargo
Wells Fargo
$1,400→$1,280
Buy
34.10%
Upside
Reiterated
04/01/26
Eli Lilly & Co (LLY) Gets a Buy from Wells Fargo
Morgan Stanley Analyst forecast on LLY
Terence Flynn
Morgan Stanley
Morgan Stanley
$1,290→$1,313
Buy
37.56%
Upside
Reiterated
04/01/26
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY) and Merit Medical Systems (NASDAQ: MMSI)
Goldman Sachs Analyst forecast on LLY
Asad Haider
Goldman Sachs
Goldman Sachs
$1,145→$1,260
Buy
32.00%
Upside
Assigned
04/01/26
Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (NASDAQ: DFTX) and Eli Lilly & Co (NYSE: LLY)
Scotiabank Analyst forecast on LLY
Louise Chen
Scotiabank
Scotiabank
$1,300
Buy
36.19%
Upside
Reiterated
04/01/26
Scotiabank Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
Bank of America Securities Analyst forecast on LLY
Jason Gerberry
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
03/31/26
Analysts' Top Healthcare Picks: Thermo Fisher (TMO), Eli Lilly & Co (LLY)
Citi Analyst forecast on LLY
Geoff Meacham
Citi
Citi
$1,500
Buy
57.15%
Upside
Reiterated
03/31/26
Analysts Offer Insights on Healthcare Companies: Phreesia (NYSE: PHR), Palisade Bio (NASDAQ: PALI) and Eli Lilly & Co (NYSE: LLY)
BMO Capital Analyst forecast on LLY
Evan Seigerman
BMO Capital
BMO Capital
$1,300
Buy
36.19%
Upside
Reiterated
03/31/26
Eli Lilly: Strategic Neuroscience Expansion and Diversified Growth Support Continued Buy Rating
Leerink Partners Analyst forecast on LLY
David Risinger
Leerink Partners
Leerink Partners
$1,296
Buy
35.78%
Upside
Reiterated
03/30/26
Analysts' Top Healthcare Picks: Centene (CNC), Eli Lilly & Co (LLY)
Bernstein Analyst forecast on LLY
Courtney Breen
Bernstein
Bernstein
$1,300
Buy
36.19%
Upside
Reiterated
03/30/26
Bernstein Keeps Their Buy Rating on Eli Lilly & Co (LLY)
Barclays Analyst forecast on LLY
Emily Field
Barclays
Barclays
$1,350
Buy
41.43%
Upside
Reiterated
03/24/26
Barclays Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
J.P. Morgan Analyst forecast on LLY
Chris Schott
J.P. Morgan
J.P. Morgan
$1,300
Buy
36.19%
Upside
Reiterated
03/23/26
J.P. Morgan Keeps Their Buy Rating on Eli Lilly & Co (LLY)
RBC Capital Analyst forecast on LLY
Trung Huynh
RBC Capital
RBC Capital
$1,250
Buy
30.96%
Upside
Reiterated
03/19/26
Eli Lilly has "viable option' in type 2 diabetes, says RBC CapitalEli Lilly has "viable option' in type 2 diabetes, says RBC Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on LLY
Srikripa Devarakonda
Truist Financial
Truist Financial
―
Buy
―
Reiterated
04/02/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen Analyst forecast on LLY
Steve Scala
TD Cowen
TD Cowen
$1,250
Buy
30.96%
Upside
Reiterated
04/02/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Guggenheim Analyst forecast on LLY
Seamus Fernandez
Guggenheim
Guggenheim
$1,163
Buy
21.84%
Upside
Assigned
04/01/26
Eli Lilly price target lowered to $1,163 from $1,168 at GuggenheimEli Lilly price target lowered to $1,163 from $1,168 at Guggenheim
Wells Fargo Analyst forecast on LLY
Mohit Bansal
Wells Fargo
Wells Fargo
$1,400→$1,280
Buy
34.10%
Upside
Reiterated
04/01/26
Eli Lilly & Co (LLY) Gets a Buy from Wells Fargo
Morgan Stanley Analyst forecast on LLY
Terence Flynn
Morgan Stanley
Morgan Stanley
$1,290→$1,313
Buy
37.56%
Upside
Reiterated
04/01/26
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY) and Merit Medical Systems (NASDAQ: MMSI)
Goldman Sachs Analyst forecast on LLY
Asad Haider
Goldman Sachs
Goldman Sachs
$1,145→$1,260
Buy
32.00%
Upside
Assigned
04/01/26
Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (NASDAQ: DFTX) and Eli Lilly & Co (NYSE: LLY)
Scotiabank Analyst forecast on LLY
Louise Chen
Scotiabank
Scotiabank
$1,300
Buy
36.19%
Upside
Reiterated
04/01/26
Scotiabank Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
Bank of America Securities Analyst forecast on LLY
Jason Gerberry
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
03/31/26
Analysts' Top Healthcare Picks: Thermo Fisher (TMO), Eli Lilly & Co (LLY)
Citi Analyst forecast on LLY
Geoff Meacham
Citi
Citi
$1,500
Buy
57.15%
Upside
Reiterated
03/31/26
Analysts Offer Insights on Healthcare Companies: Phreesia (NYSE: PHR), Palisade Bio (NASDAQ: PALI) and Eli Lilly & Co (NYSE: LLY)
BMO Capital Analyst forecast on LLY
Evan Seigerman
BMO Capital
BMO Capital
$1,300
Buy
36.19%
Upside
Reiterated
03/31/26
Eli Lilly: Strategic Neuroscience Expansion and Diversified Growth Support Continued Buy Rating
Leerink Partners Analyst forecast on LLY
David Risinger
Leerink Partners
Leerink Partners
$1,296
Buy
35.78%
Upside
Reiterated
03/30/26
Analysts' Top Healthcare Picks: Centene (CNC), Eli Lilly & Co (LLY)
Bernstein Analyst forecast on LLY
Courtney Breen
Bernstein
Bernstein
$1,300
Buy
36.19%
Upside
Reiterated
03/30/26
Bernstein Keeps Their Buy Rating on Eli Lilly & Co (LLY)
Barclays Analyst forecast on LLY
Emily Field
Barclays
Barclays
$1,350
Buy
41.43%
Upside
Reiterated
03/24/26
Barclays Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
J.P. Morgan Analyst forecast on LLY
Chris Schott
J.P. Morgan
J.P. Morgan
$1,300
Buy
36.19%
Upside
Reiterated
03/23/26
J.P. Morgan Keeps Their Buy Rating on Eli Lilly & Co (LLY)
RBC Capital Analyst forecast on LLY
Trung Huynh
RBC Capital
RBC Capital
$1,250
Buy
30.96%
Upside
Reiterated
03/19/26
Eli Lilly has "viable option' in type 2 diabetes, says RBC CapitalEli Lilly has "viable option' in type 2 diabetes, says RBC Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Eli Lilly & Co

3 Months
xxx
Success Rate
26/35 ratings generated profit
74%
Average Return
+8.32%
reiterated a xxx
 rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 74.29% of your transactions generating a profit, with an average return of +8.32% per trade.
1 Year
Geoff MeachamCiti
Success Rate
40/45 ratings generated profit
89%
Average Return
+37.52%
reiterated a buy rating 4 days ago
Copying Geoff Meacham's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +37.52% per trade.
2 Years
xxx
Success Rate
39/39 ratings generated profit
100%
Average Return
+72.78%
reiterated a xxx
 rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +72.78% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LLY Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
2
2
Buy
90
71
71
89
80
Hold
13
10
12
12
9
Sell
0
0
0
2
2
Strong Sell
0
0
0
0
0
total
103
81
83
105
93
In the current month, LLY has received 82 Buy Ratings, 9 Hold Ratings, and 2 Sell Ratings. LLY average Analyst price target in the past 3 months is 1,249.83.
Each month's total comprises the sum of three months' worth of ratings.

LLY Financial Forecast

LLY Earnings Forecast

Next quarter’s earnings estimate for LLY is $7.26 with a range of $3.63 to $8.56. The previous quarter’s EPS was $7.54. LLY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year LLY has Performed in-line its overall industry.
Next quarter’s earnings estimate for LLY is $7.26 with a range of $3.63 to $8.56. The previous quarter’s EPS was $7.54. LLY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year LLY has Performed in-line its overall industry.

LLY Sales Forecast

Next quarter’s sales forecast for LLY is $17.67B with a range of $13.64B to $19.38B. The previous quarter’s sales results were $19.29B. LLY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year LLY has Performed in-line its overall industry.
Next quarter’s sales forecast for LLY is $17.67B with a range of $13.64B to $19.38B. The previous quarter’s sales results were $19.29B. LLY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year LLY has Performed in-line its overall industry.

LLY Stock Forecast FAQ

What is LLY’s average 12-month price target, according to analysts?
Based on analyst ratings, Eli Lilly & Co’s 12-month average price target is 1,249.83.
    What is LLY’s upside potential, based on the analysts’ average price target?
    Eli Lilly & Co has 30.94% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is LLY a Buy, Sell or Hold?
          Eli Lilly & Co has a consensus rating of Strong Buy which is based on 18 buy ratings, 2 hold ratings and 1 sell ratings.
            What is Eli Lilly & Co’s price target?
            The average price target for Eli Lilly & Co is 1,249.83. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $1,500.00 ,the lowest forecast is $850.00. The average price target represents 30.94% Increase from the current price of $954.52.
              What do analysts say about Eli Lilly & Co?
              Eli Lilly & Co’s analyst rating consensus is a Strong Buy. This is based on the ratings of 21 Wall Streets Analysts.
                How can I buy shares of LLY?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.